DNA content is associated with malignancy of intracranial neoplasms

[1]  Sofia Markoula,et al.  Management of meningiomas , 2010, Clinical Neurology and Neurosurgery.

[2]  G. Alexiou,et al.  Correlation of glioma proliferation assessed by flow cytometry with 99mTc-Tetrofosmin SPECT uptake , 2009, Clinical Neurology and Neurosurgery.

[3]  G. Alexiou,et al.  Evaluation of meningioma aggressiveness by 99mTc-Tetrofosmin SPECT , 2008, Clinical Neurology and Neurosurgery.

[4]  W. Sakr,et al.  Cellular DNA content parameters as prognostic indicators in human astrocytomas , 2004, Journal of Neuro-Oncology.

[5]  R. Prayson.  Cell Proliferation and Tumors of the Central Nervous System, Part II: Radiolabeling, Cytometric, and Immunohistochemical Techniques , 2002, Journal of neuropathology and experimental neurology.

[6]  A. Órfão,et al.  Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors. , 1999, Cytometry.

[7]  J. Meixensberger,et al.  DNA ploidy and cell‐cycle analysis in intracranial meningiomas and hemangiopericytomas: A study with high‐resolution DNA flow cytometry , 1998, International journal of cancer.

[8]  W. Giaretti,et al.  Consensus Report of the Task Force on Standardisation of DNA Flow Cytometry in Clinical Pathology , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[9]  J. Sarasa,et al.  Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. , 1997, Oncology.

[10]  J. Battermann,et al.  S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors. , 1997, Radiation oncology investigations.

[11]  J. Meixensberger,et al.  Prognostic significance of nuclear DNA content in human meningiomas: a prospective study. , 1996, Acta neurochirurgica. Supplement.

[12]  S. Coons,et al.  Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. , 1994, Neurosurgery.

[13]  Brian H. Mayall,et al.  Guidelines for implementation of clinical DNA cytometry , 1993 .

[14]  R. Kiss,et al.  Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients , 1992 .

[15]  C. V. van Eden,et al.  Prognostic relevance of DNA flow cytometry in oligodendroglioma , 1992, Cancer.

[16]  R. Battersby,et al.  The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. , 1989, Journal of neurosurgery.

[17]  S. Barnwell,et al.  Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. , 1988, Journal of neurosurgery.

[18]  J. Ironside,et al.  DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. , 1987, Journal of neurosurgery.

[19]  O. Laerum,et al.  Modal DNA content of human intracranial neoplasms studied by flow cytometry. , 1980, Journal of neurosurgery.